Skip to main content

Wales Specialist Virology Centre

Public Health Wales Microbiology Cardiff
University Hospital of Wales

Heath Park
Cardiff
CF14 4XW

DX 6070100
Cardiff 90 CF

Tel:  029 2074 2178     
Out of hours: 029 2074 7747     
Fax:  029 2074 6403     
 

Dr Rachel Jones: Consultant Virologist

Dr Jaisi Sinha: Consultant Virologist

Dr Catherine Moore: Consultant Clinical Scientist Virology

Dr Laura Dexter: Consultant Virologist

Dr Susie Froude: Consultant Microbiologist/Infectious Diseases with an interest in Virology

Jonathan Evans: Operational Manager/Lead BMS

Rhianydd Rees: Deputy Operational Manager

 

 

Test Profiles and Turnaround Times

Due to the provision of the SARS-Cov2 (CoVID-19) testing, the Wales Specialist Virology Centre cannot currently provide guaranteed turnaround times for our other tests. Please check Welsh Clinical Portal before contacting the laboratory for results. If urgent testing is required, please contact the duty Consultant Virologist to discuss.

For NON-COVID 19 tests, if urgent testing is required, please contact the duty Consultant Virologist to discuss.
 
Please refer to the User Handbook on the main Cardiff Microbiology page for specimen collection and transport requirements.
 
Electronic test requesting is available for certain tests via the Welsh Clinical Portal.  Please contact your local ETR project team for more information (details are on the WCP website).

Public Health Wales Microbiology Division has been awarded UKAS accreditation for compliance with ISO 15189:2012.  The following local tests are currently outside of our accredited scope due to service improvement projects and will be considered for assessment by UKAS at a later date.

  • Luminex Magpix RPP + COVID assay
  • Rota/Adeno rapid test
  • Antistreptolysin-O titre in serology
  • Testing of Dried Blood Spot Specimens
  • Syphilis TPHA/RPR confirmatory serology assays
  • VZV IgM serology assay

We have recently introduced a number of testing platforms in our laboratories to detect SARS-Cov-2 (COVID 19). Whilst these tests are not currently on our UKAS accredited scope for compliance with ISO 15189:2012, ongoing assurance of quality is provided by internal and external quality assurance procedures, quality control and training. This is all evidenced and contained within our Quality Management System.


During 2021, the serology assays performed on the Abbott Architect platform will be transferred to the Alinity i platform. Following the verification of the new platform, the serology assays will temporarily be outside of our accredited scope, until the next accreditation assessment by UKAS.